Enantioselective Resolution of N-(tert-Butoxycarbonyl)- 2-azabicyclo[2.2.1]hept-5-en-3-one

Pu-rui LI,Jian-jian HU,Xiao-chuan WANG,Ling-ling ZHANG,Xiao-zhong WANG
DOI: https://doi.org/10.3969/j.issn.1003-9015.2015.05.021
2015-01-01
Abstract:(?)-(1R,4S)-N-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]hept-5-en-3-one is an important intermediate of abacavir which is widely used in AIDS treatment. This chemical was prepared with 2-azabicyclo-[2.2.1]hept-5-en-3-one(2) as the starting material in this study. The starting material(2) was first reacted with (Boc)2O to give the raceme (±)-N-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]hept-5-en-3-one(3) via amidation. The key intermediate was preparedvia a prominent turnover from the raceme(3) with immobilized lipases, and its structure was identified by1H-NMR. The optimum conditions of the enzymatic reaction were as follows: Lipozyme RM IM andisopropyl elther were used as the enzyme reaction catalyst, and reaction solvent separatively, the mass ratio of enzyme: substrate 1.5/2.0 and the reaction temperature of 30℃. The yield can reach to 46.5% under these optimal conditions with enantiomeric excess up to 99%. This synthetic process is suitable for large-scale manufacture due to the cheap available material and higher catalytic activity and selectivity of the lipase.
What problem does this paper attempt to address?